65--65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment: M5-Q50A-03-R8

SOL #: M5Q50A03R8Pre-Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NAC FEDERAL SUPPLY SCHEDULE (36F797)
HINES, IL, 60141, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Medical/Dental/Veterinary Eqpt/Supp (65)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 21, 2018
2
Last Updated
May 27, 2026
3
Response Deadline
Jun 21, 2023, 5:00 AM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA) has awarded Neurocrine Biosciences, Inc. a Federal Supply Schedule (FSS) contract for Drugs and Biologicals (PSC 6505). This award is effective from June 1, 2026, to May 31, 2031.

Award Details

This notice confirms the award of a VA Federal Supply Schedule contract to Neurocrine Biosciences, Inc. The contract falls under Product Service Code 6505 (Drugs and Biologicals) and NAICS Code 325412 (Pharmaceutical and Medicine Manufacturing). This is an existing contract under the broader standing solicitation M5-Q50A-03-R8, which is a Multiple Award Schedule for pharmaceutical products.

Contract Scope

The VA FSS program for Drugs, Pharmaceuticals & Hematology Related Products (FSC Group 65, Part I, Section B) provides a mechanism for federal agencies to procure a wide range of pharmaceutical items. Contracts awarded under this solicitation are typically Fixed-Price with Economic Price Adjustment, Indefinite Delivery, Indefinite Quantity (IDIQ).

Period of Performance

The contract awarded to Neurocrine Biosciences, Inc. is for a 5-year period, commencing on June 1, 2026, and concluding on May 31, 2031.

Set-Aside

While this specific award notice does not specify a set-aside, the underlying FSS solicitation is open to all responsible offerors. Individual task orders placed against FSS contracts may incorporate various small business set-asides, including for HUBZone, veteran-owned, service-disabled veteran-owned, small disadvantaged, women-owned, and economically disadvantaged women-owned small businesses.

Additional Information

This is an award notice for informational purposes and does not represent a current solicitation for new bids. For further details regarding the VA Federal Supply Schedule program, contact the FSS Help Desk at FSS.Help@va.gov or 708-786-7737.

People

Points of Contact

FSS Helpdesk lydia.mckay@va.govPRIMARY

Files

Files

No files attached to this opportunity

Versions

Version 19
Award Notice
Posted: May 27, 2026
View
Version 18
Award Notice
Posted: Apr 27, 2026
View
Version 17
Pre-Solicitation
Posted: Apr 20, 2026
View
Version 16
Pre-Solicitation
Posted: Apr 16, 2026
View
Version 15
Pre-Solicitation
Posted: Apr 16, 2026
View
Version 14
Pre-Solicitation
Posted: Apr 2, 2026
View
Version 13
Pre-Solicitation
Posted: Mar 18, 2026
View
Version 12
Award Notice
Posted: Feb 13, 2026
View
Version 11
Pre-Solicitation
Posted: Dec 23, 2025
View
Version 10
Pre-Solicitation
Posted: Dec 10, 2025
View
Version 9
Pre-Solicitation
Posted: Dec 10, 2025
View
Version 8
Pre-Solicitation
Posted: Dec 1, 2022
View
Version 7
Pre-Solicitation
Posted: Mar 31, 2020
View
Version 6
Pre-Solicitation
Posted: Jan 9, 2020
View
Version 5
Pre-Solicitation
Posted: Oct 23, 2019
View
Version 4
Pre-Solicitation
Posted: Mar 29, 2019
View
Version 3Viewing
Pre-Solicitation
Posted: Sep 10, 2018
Version 2
Pre-Solicitation
Posted: Jun 21, 2018
View
Version 1
Pre-Solicitation
Posted: Jun 21, 2018
View
6505--Neurocrine Biosciences, Inc. Effective 06/01/2026 - 05/31/2031 | GovScope